Works matching AU Pan, Qingbo
Results: 7
Safety and Immunogenicity After Primary and Booster Inactivated SARS-Cov-2 Vaccination in Patients with Autoimmune Liver Diseases.
- Published in:
- Journal of Clinical & Translational Hepatology, 2024, v. 12, n. 2, p. 162, doi. 10.14218/JCTH.2023.00049
- By:
- Publication type:
- Article
LDoS attack detection method based on traffic classification prediction.
- Published in:
- IET Information Security (Wiley-Blackwell), 2022, v. 16, n. 2, p. 86, doi. 10.1049/ise2.12046
- By:
- Publication type:
- Article
Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors.
- Published in:
- Cancer Communications, 2023, v. 43, n. 2, p. 280, doi. 10.1002/cac2.12368
- By:
- Publication type:
- Article
Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo‐related genes in hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 9, p. 3139, doi. 10.1002/cam4.3890
- By:
- Publication type:
- Article
Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1028246
- By:
- Publication type:
- Article
The β3/5 Integrin-MMP9 Axis Regulates Pulmonary Inflammatory Response and Endothelial Leakage in Acute Lung Injury.
- Published in:
- Journal of Inflammation Research, 2021, v. 14, p. 5079, doi. 10.2147/JIR.S331939
- By:
- Publication type:
- Article
Humoral responses after primary and booster SARS‐CoV‐2 inactivated vaccination in patients with chronic hepatitis B virus infection: A longitudinal observational study.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 4, p. 1, doi. 10.1002/jmv.28695
- By:
- Publication type:
- Article